All terms in HP

Label Id Description
abnormal cell CL_0001061 [A cell found in an organism or derived from an organism exhibiting a phenotype that deviates from the expected phenotype of any native cell type of that organism. Abnormal cells are typically found in disease states or disease models.]
effector memory CD8-positive, alpha-beta T cell, terminally differentiated CL_0001062 [A CD8-positive, alpha beta memory T cell with the phenotype CD45RA-positive, CD45RO-negative, and CCR7-negative.]
CD8-positive, alpha-beta memory T cell CL_0000909 [A CD8-positive, alpha-beta T cell that has differentiated into a memory T cell.]
effector memory CD45RA-positive, alpha-beta T cell, terminally differentiated CL_4030002 [An alpha-beta memory T cell with the phenotype CD45RA-positive.]
Decreased T cell activation HP_0005419 [Decreased or impaired activation of T cells in response to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.]
Abnormal T cell activation HP_0410035 [Any abnormality in the activation of T cells, i.e. the change in morphology and behavior of a mature or immature T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.]
Decreased circulating androgen concentration HP_0030349 [A reduction in the blood concentration of an androgen, that is, of a steroid hormone that controls development and maintenance of masculine characteristics. The androgens include testosterone and Dehydroepiandrosterone.]
xanthine dehydrogenase/oxidase (human) PR_P47989 [A xanthine dehydrogenase/oxidase that is encoded in the genome of human.]
Abnormal circulating sex hormone concentration HP_0033799 [Any deviation from the normal concentration of a sex hormone in the blood circulation]
regulation of eating behavior NBO_0000063
regulation of feeding behavior NBO_0002436
Depletion of components of the alternative complement pathway HP_0005389 [An abnormal reduction in the components of the alternative complement pathway, such as the C3 protein or its cleavage products.]
Abnormal circulating luteinizing hormone concentration HP_0030345 [An anomaly of the circulating level of luteinizing hormone (LH).]
Abnormal circulating follicle-stimulating hormone concentration HP_0030346 [An anomaly of the circulating level of follicle-stimulating hormone (FSH).]
regulation of drinking behavior NBO_0000064
Combined immunodeficiency HP_0005387 [A group of phenotypically heterogeneous genetic disorders characterized by profound deficiencies of T- and B-cell function, which predispose the patients to both infectious and noninfectious complications.]
positive regulation of serotonin secretion GO_0014064 [Any process that activates or increases the frequency, rate or extent of the regulated release of serotonin.]
regulation of serotonin secretion GO_0014062 [Any process that modulates the frequency, rate or extent of the regulated release of serotonin.]
negative regulation of serotonin secretion GO_0014063 [Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of serotonin.]
Defective B cell activation HP_0005384 [A reduced ability of a B cell to become activated, i.e., the change in morphology and behavior of]